{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,8,12]],"date-time":"2023-08-12T04:19:45Z","timestamp":1691813985071},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2023,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Objective<\/jats:title>\n                <jats:p>To understand the knowledge status, obstacle factors, and management confidence of oncology nurses on the bone health of cancer patients, and in addition to provide reference for establishing bone health knowledge training system for oncology nurses and guiding them to manage bone health of cancer patients.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 602 nurses engaged in oncology nursing in 6 hospitals in Hebei Province were selected by cluster sampling, and an online anonymous survey was conducted by sending questionnaires to oncology nurses from the Hebei Cancer Prevention and Control Association. The questionnaire was developed by the study team. There are 4 parts, namely general information, nurses\u2019 role and job responsibilities, knowledge of skeletal-related events (SREs) and cancer treatment\u2013induced bone loss (CTIBL), and understanding and confidence in bone health management, for a total of 33 questions.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Thirty-seven percent of oncology nurses received training on bone health and other related contents; 40.48% of oncology nurses used domestic and foreign guidelines when managing patients with bone metastases or CTIBL. Only approximately one-third of oncology nurses had confidence in managing the side effects of bone metastases and bone modification drugs and identifying patients at risk of CTIBL and fracture; only 33.04% of oncology nurses believed that weight-bearing exercise can prevent bone loss; less than 50% of oncology nurses believed that aromatase inhibitor therapy, ovarian suppression therapy, androgen deprivation therapy, and low body weight were risk factors for pathological fractures. The reasons that hindered oncology nurses from optimizing the management of patients with bone metastases and understanding the preventive measures and risk factors for bone loss mainly included lack of relevant knowledge training, lack of understanding of effective intervention measures, and lack of training and professionalism of specialized nurses, including insufficient development time and guidelines for clinical nursing practice.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Managers must continuously improve the training system of oncology nurses, enrich the content of training pertaining to bone health for cancer patients, formulate clinical nursing practice guidelines, and give oncology nurses more time for professional development.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00520-023-07966-2","type":"journal-article","created":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T06:02:49Z","timestamp":1690869769000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["A cross-sectional study on Chinese oncology nurses\u2019 knowledge of bone health among cancer patients"],"prefix":"10.1007","volume":"31","author":[{"given":"Jing","family":"Shan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumei","family":"Lv","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianhua","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jingwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuangyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Congcong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,1]]},"reference":[{"issue":"7","key":"7966_CR1","doi-asserted-by":"publisher","first-page":"482","DOI":"10.21037\/atm.2020.03.55","volume":"8","author":"JF Huang","year":"2020","unstructured":"Huang JF, Shen J, Li X et al (2020) Incidence of patients with bone metastases at diagnosis of solid tumors in adults: a large population-based study. Ann Transl Med 8(7):482","journal-title":"Ann Transl Med"},{"issue":"1","key":"7966_CR2","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12885-017-3922-0","volume":"18","author":"RK Hernandez","year":"2018","unstructured":"Hernandez RK, Wade SW, Reich A, Pirolli M, Liede A, Lyman GH (2018) Incidence of bone metastases in patients with solid tumors: analysis of oncology electronic medical records in the United States. BMC Cancer 18(1):44","journal-title":"BMC Cancer"},{"issue":"12","key":"7966_CR3","doi-asserted-by":"publisher","first-page":"3279","DOI":"10.1007\/s00520-013-1887-3","volume":"21","author":"G Oster","year":"2013","unstructured":"Oster G, Lamerato L, Glass AG et al (2013) Natural history of skeletal-related events in patients with breast, lung, or prostate cancer and metastases to bone: a 15-year study in two large US health systems. Support Care Cancer 21(12):3279\u20133286","journal-title":"Support Care Cancer"},{"issue":"9","key":"7966_CR4","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.ctrv.2015.09.003","volume":"41","author":"S D\u2019Oronzo","year":"2015","unstructured":"D\u2019Oronzo S, Stucci S, Tucci M, Silvestris F (2015) Cancer treatment-induced bone loss (CTIBL): pathogenesis and clinical implications. Cancer Treat. Rev 41(9):798\u2013808","journal-title":"Cancer Treat. Rev"},{"key":"7966_CR5","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1186\/s12885-015-1407-6","volume":"15","author":"A Conway","year":"2015","unstructured":"Conway A, McCarthy AL, Lawrence P, Clark RA (2015) The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review. BMC Cancer 15:366","journal-title":"BMC Cancer"},{"issue":"4","key":"7966_CR6","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1586\/14737167.2013.820959","volume":"13","author":"JA Carter","year":"2013","unstructured":"Carter JA, Ji X, Botteman MF (2013) Clinical, economic and humanistic burdens of skeletal-related events associated with bone metastases. Expert Rev Pharmacoecon Outcomes Res 13(4):483\u2013496","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"11","key":"7966_CR7","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/14712598.2020.1814731","volume":"20","author":"E Dell\u2019Aquila","year":"2020","unstructured":"Dell\u2019Aquila E, Armento G, Iuliani M, Simonetti S, D\u2019Onofrio L, Zeppola T, Santini D (2020) Denosumab for cancer-related bone loss. Expert Opin Biol Ther 20(11):1261\u20131274","journal-title":"Expert Opin Biol Ther"},{"key":"7966_CR8","doi-asserted-by":"publisher","first-page":"3529","DOI":"10.2147\/CMAR.S300063","volume":"13","author":"DR Flora","year":"2021","unstructured":"Flora DR, Carlson KB, Fuehrer DC et al (2021) Assessment of bone health education in US multiple myeloma and solid tumor patients at risk for skeletal-related events. Cancer Manag Res 13:3529\u20133537","journal-title":"Cancer Manag Res"},{"issue":"2","key":"7966_CR9","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1007\/s00223-017-0369-x","volume":"102","author":"C Handforth","year":"2018","unstructured":"Handforth C, D\u2019, Oronzo S, Coleman R, Brown J (2018) Cancer treatment and bone health. Calcif Tissue Int 102(2):251\u2013264","journal-title":"Calcif Tissue Int"},{"issue":"4","key":"7966_CR10","doi-asserted-by":"publisher","first-page":"241","DOI":"10.2519\/jospt.2017.6969","volume":"47","author":"R Zhao","year":"2017","unstructured":"Zhao R, Zhang M, Zhang Q (2017) The effectiveness of combined exercise interventions for preventing postmenopausal bone loss: a systematic review and meta-analysis. J Orthop Sports Phys Ther 47(4):241\u2013251","journal-title":"J Orthop Sports Phys Ther"},{"key":"7966_CR11","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.critrevonc.2017.09.003","volume":"120","author":"A Kommalapati","year":"2017","unstructured":"Kommalapati A, Tella SH, Esquivel MA, Correa R (2017) Evaluation and management of skeletal disease in cancer care. Crit Rev Oncol Hematol 120:217\u2013226","journal-title":"Crit Rev Oncol Hematol"},{"key":"7966_CR12","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ctrv.2019.05.003","volume":"76","author":"R von Moos","year":"2019","unstructured":"von Moos R, Costa L, Gonzalez-Suarez E, Terpos E, Niepel D, Body JJ (2019) Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody. Cancer Treat Rev 76:57\u201367","journal-title":"Cancer Treat Rev"},{"issue":"3","key":"7966_CR13","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1007\/s00520-019-04858-2","volume":"28","author":"L Drudge-Coates","year":"2020","unstructured":"Drudge-Coates L, van Muilekom E, de la Torre-Montero JC et al (2020) Management of bone health in patients with cancer: a survey of specialist nurses. Support Care Cancer 28(3):1151\u20131162","journal-title":"Support Care Cancer"},{"issue":"1","key":"7966_CR14","doi-asserted-by":"publisher","first-page":"22","DOI":"10.7257\/1053-816X.2016.36.1.22","volume":"36","author":"B Turner","year":"2016","unstructured":"Turner B, Ali S, Drudge-Coates L, Pati J, Nargund V, Wells P (2016) Skeletal health part 2: development of a nurse practitioner bone support clinic for urologic patients. Urol Nurs 36(1):22\u201326","journal-title":"Urol Nurs"},{"issue":"4","key":"7966_CR15","doi-asserted-by":"publisher","first-page":"209-14; quiz 21","DOI":"10.1097\/NOR.0b013e31829a4da3","volume":"32","author":"L Monczewski","year":"2013","unstructured":"Monczewski L (2013) Managing bone metastasis in the patient with advanced cancer. Orthop Nurs 32(4):209-14; quiz 215-6","journal-title":"Orthop Nurs"},{"issue":"8","key":"7966_CR16","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1002\/pon.5678","volume":"30","author":"A Sender","year":"2021","unstructured":"Sender A, Friedrich M, Leuteritz K et al (2021) Psychosocial aftercare of adolescent and young adult cancer survivors in Germany: awareness, utilisation, satisfaction and associated factors. Psychooncology 30(8):1311\u20131321","journal-title":"Psychooncology"},{"issue":"12","key":"7966_CR17","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1007\/s00520-015-2887-2","volume":"23","author":"C Campbell-Baird","year":"2015","unstructured":"Campbell-Baird C, Harrelson S, Frey G, Balakumaran A (2015) Clinical efficacy of denosumab versus bisphosphonates for the prevention of bone complications: implications for nursing. Support Care Cancer 23(12):3625\u20133632","journal-title":"Support Care Cancer"},{"key":"7966_CR18","doi-asserted-by":"publisher","first-page":"103718","DOI":"10.1016\/j.ijnurstu.2020.103718","volume":"118","author":"I Stewart","year":"2021","unstructured":"Stewart I, Leary A, Khakwani A et al (2021) Do working practices of cancer nurse specialists improve clinical outcomes? Retrospective cohort analysis from the English National Lung Cancer Audit. Int J Nurs Stud 118:103718","journal-title":"Int J Nurs Stud"},{"issue":"8","key":"7966_CR19","doi-asserted-by":"publisher","first-page":"2121","DOI":"10.1038\/bjc.2013.568","volume":"109","author":"J Cockle-Hearne","year":"2013","unstructured":"Cockle-Hearne J, Charnay-Sonnek F, Denis L et al (2013) The impact of supportive nursing care on the needs of men with prostate cancer: a study across seven European countries. Br J Cancer 109(8):2121\u20132130","journal-title":"Br J Cancer"},{"issue":"3","key":"7966_CR20","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1080\/07347332.2011.563342","volume":"29","author":"J Sussman","year":"2011","unstructured":"Sussman J, Howell D, Bainbridge D et al (2011) The impact of specialized oncology nursing on patient supportive care outcomes. J Psychosoc Oncol 29(3):286\u2013307","journal-title":"J Psychosoc Oncol"},{"issue":"9","key":"7966_CR21","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1007\/s00520-020-05440-x","volume":"28","author":"L Drudge-Coates","year":"2020","unstructured":"Drudge-Coates L, Van den Wyngaert T, Schi\u00f8dt M, van Muilekom H, Demonty G, Otto S (2020) Preventing, identifying, and managing medication-related osteonecrosis of the jaw: a practical guide for nurses and other allied healthcare professionals. Support Care Cancer 28(9):4019\u20134029","journal-title":"Support Care Cancer"},{"key":"7966_CR22","doi-asserted-by":"publisher","first-page":"100273","DOI":"10.1016\/j.jbo.2019.100273","volume":"21","author":"M Mark","year":"2020","unstructured":"Mark M, Th\u00fcrlimann B, Ribi K et al (2020) Patterns of care for patients with metastatic bone disease in solid tumors: a cross-sectional study from Switzerland (SAKK 95\/16). J Bone Oncol 21:100273","journal-title":"J Bone Oncol"},{"issue":"13-14","key":"7966_CR23","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1111\/jocn.15268","volume":"29","author":"SC Hussain Rawther","year":"2020","unstructured":"Hussain Rawther SC, Pai MS, Fernandes DJ, Mathew S, Chakrabarty J, Devi ES (2020) Specialist nurse initiated interventions in breast cancer care: a systematic review of randomised controlled trials. J Clin Nurs 29(13-14):2161\u20132180","journal-title":"J Clin Nurs"},{"issue":"3","key":"7966_CR24","first-page":"311","volume":"15","author":"Z Na","year":"2015","unstructured":"Na Z, Yuanping P, Guobi W, etc. (2015) Construction and effectiveness of Chongqing oncology nurse training base. Nursing 15(3):311\u2013314","journal-title":"Nursing"},{"issue":"10","key":"7966_CR25","first-page":"457","volume":"10","author":"S Ruchun","year":"2013","unstructured":"Ruchun S, Aifeng M (2013) Practice and experience of training tumor nurses in Jiangsu Province. Chinese Nurs.Educ 10(10):457\u2013459","journal-title":"Chinese Nurs.Educ"},{"issue":"06","key":"7966_CR26","first-page":"444","volume":"11","author":"Z Shuxiang","year":"2014","unstructured":"Shuxiang Z, Bo X (2014) Practical research on clinical training of oncology nurses. Chinese Nurs.Educ 11(06):444\u2013446","journal-title":"Chinese Nurs.Educ"},{"issue":"3","key":"7966_CR27","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.ejon.2009.12.003","volume":"14","author":"M Morris","year":"2010","unstructured":"Morris M, Cruickshank S (2010) Bisphosphonate-related osteonecrosis of the jaw in cancer patients: implications for nurses. Eur J Oncol Nurs 14(3):205\u2013210","journal-title":"Eur J Oncol Nurs"},{"issue":"4","key":"7966_CR28","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1016\/j.soncn.2015.08.009","volume":"31","author":"S Corcoran","year":"2015","unstructured":"Corcoran S, Dunne M, McCabe MS (2015) The role of advanced practice nurses in cancer survivorship care. Semin Oncol Nurs 31(4):338\u2013347","journal-title":"Semin Oncol Nurs"},{"issue":"18","key":"7966_CR29","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.2217\/fon-2022-0098","volume":"18","author":"Z Wei","year":"2022","unstructured":"Wei Z, Pan B, Jia D, Yu Y (2022) Long-term safety and efficacy of bisphosphonate therapy in advanced lung cancer with bone metastasis. Future Oncol 18(18):2257\u20132267","journal-title":"Future Oncol"},{"issue":"41","key":"7966_CR30","doi-asserted-by":"publisher","first-page":"6239","DOI":"10.2174\/138161282341180215105902","volume":"23","author":"B Li","year":"2017","unstructured":"Li B (2017) Editorial: New strategies for the prevention and treatment of bone loss. Curr Pharm Des 23(41):6239\u20136240","journal-title":"Curr Pharm Des"},{"key":"7966_CR31","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/164_2019_340","volume":"262","author":"P Vestergaard","year":"2020","unstructured":"Vestergaard P (2020) Drugs causing bone loss. Handb Exp Pharmacol 262:475\u2013497","journal-title":"Handb Exp Pharmacol"},{"issue":"27","key":"7966_CR32","doi-asserted-by":"publisher","first-page":"3440","DOI":"10.1200\/JCO.2013.50.9737","volume":"31","author":"K Zaman","year":"2013","unstructured":"Zaman K, Thuerlimann B, Aebi S (2013) Optimal sequence of tamoxifen and aromatase inhibitors to prevent bone loss. J. Clin. Oncol 31(27):3440\u20133441","journal-title":"J. Clin. Oncol"},{"issue":"Suppl 1","key":"7966_CR33","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1053\/j.seminoncol.2010.06.005","volume":"37","author":"A Lipton","year":"2010","unstructured":"Lipton A (2010) Bone loss prevention in cancer: new developments and perspectives. Semin Oncol 37(Suppl 1):S1\u2013S2","journal-title":"Semin Oncol"},{"issue":"2","key":"7966_CR34","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1007\/s11914-014-0252-x","volume":"13","author":"A Garg","year":"2015","unstructured":"Garg A, Leitzel K, Ali S, Lipton A (2015) Antiresorptive therapy in the management of cancer treatment-induced bone loss. Curr Osteoporos Rep 13(2):73\u201377","journal-title":"Curr Osteoporos Rep"},{"key":"7966_CR35","doi-asserted-by":"publisher","first-page":"115330","DOI":"10.1016\/j.bone.2020.115330","volume":"136","author":"J Compston","year":"2020","unstructured":"Compston J (2020) Practical guidance for the use of bisphosphonates in osteoporosis. Bone. 136:115330","journal-title":"Bone."},{"issue":"3","key":"7966_CR36","first-page":"50","volume":"11","author":"JR Gralow","year":"2013","unstructured":"Gralow JR, Biermann JS, Farooki A et al (2013) NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw 11(3):50\u201351","journal-title":"J Natl Compr Canc Netw"},{"issue":"3","key":"7966_CR37","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1002\/jbmr.3659","volume":"34","author":"S Watson","year":"2019","unstructured":"Watson S, Weeks B, Weis L, Harding A, Horan S, Beck B (2019) High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial. J Bone Miner Res 34(3):572","journal-title":"J Bone Miner Res"},{"issue":"1","key":"7966_CR38","doi-asserted-by":"publisher","first-page":"74","DOI":"10.3390\/nu14010074","volume":"14","author":"M Rondanelli","year":"2021","unstructured":"Rondanelli M, Faliva MA, Barrile GC et al (2021) Nutrition, physical activity, and dietary supplementation to prevent bone mineral density loss: a food pyramid. Nutrients 14(1):74","journal-title":"Nutrients"},{"issue":"15","key":"7966_CR39","doi-asserted-by":"publisher","first-page":"3640","DOI":"10.3390\/cancers14153640","volume":"14","author":"R Coleman","year":"2022","unstructured":"Coleman R (2022) Bone-targeted agents and metastasis prevention. Cancers 14(15):3640","journal-title":"Cancers"},{"issue":"6","key":"7966_CR40","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1210\/jc.2011-3045","volume":"97","author":"NB Watts","year":"2012","unstructured":"Watts NB, Adler RA, Bilezikian JP et al (2012) Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 97(6):1802\u20131822","journal-title":"J Clin Endocrinol Metab"},{"issue":"3","key":"7966_CR41","first-page":"518","volume":"108","author":"M Hupe","year":"2020","unstructured":"Hupe M (2020) Ovarian suppression for adjuvant treatment of hormone receptor positive early breast cancer (Review). Lean Library. J Med Libr Assoc 108(3):518\u2013519","journal-title":"Lean Library. J Med Libr Assoc"},{"issue":"5","key":"7966_CR42","doi-asserted-by":"publisher","first-page":"357","DOI":"10.7326\/M17-1800","volume":"167","author":"A Farooki","year":"2017","unstructured":"Farooki A, Scher HI (2017) Maintaining bone health during hormonal therapy for prostate cancer. Ann Intern Med 167(5):357\u2013358","journal-title":"Ann Intern Med"},{"issue":"8","key":"7966_CR43","first-page":"17519","volume":"13","author":"R Kareem","year":"2021","unstructured":"Kareem R, Botleroo RA, Bhandari R et al (2021) The impact of rheumatoid arthritis on bone loss: links to osteoporosis and osteopenia. Cureus 13(8):17519","journal-title":"Cureus"},{"issue":"3","key":"7966_CR44","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1016\/S1470-2045(20)30559-3","volume":"22","author":"E Terpos","year":"2021","unstructured":"Terpos E, Zamagni E, Lentzsch S et al (2021) Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. Lancet Oncol 22(3):e119\u2013e130","journal-title":"Lancet Oncol"},{"issue":"6","key":"7966_CR45","doi-asserted-by":"publisher","first-page":"e29","DOI":"10.1016\/j.rx.2013.04.003","volume":"56","author":"LM Mor\u00e1n Blanco","year":"2014","unstructured":"Mor\u00e1n Blanco LM, Encinas RC (2014) Multiple myeloma with diffuse osteosclerosis: distinct from POEMS syndrome. Radiologia 56(6):e29\u2013e33","journal-title":"Radiologia"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-023-07966-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-023-07966-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,11]],"date-time":"2023-08-11T08:18:56Z","timestamp":1691741936000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-023-07966-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":45,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["7966"],"URL":"https:\/\/doi.org\/10.1007\/s00520-023-07966-2","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"11 March 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 August 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors agreed to the submission of the manuscript and agree to take responsibility and be accountable for the contents of the article.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"501"}}